- Home
- COMP vs ICUI Comparison
COMP vs ICUI Comparison
Compare COMP & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMP
- ICUI
- Stock Information
- Founded
- COMP 2012
- ICUI 1984
- Country
- COMP United States
- ICUI United States
- Employees
- COMP N/A
- ICUI N/A
- Industry
- COMP EDP Services
- ICUI Medical/Dental Instruments
- Sector
- COMP Technology
- ICUI Health Care
- Exchange
- COMP Nasdaq
- ICUI Nasdaq
- Market Cap
- COMP 4.3B
- ICUI 3.6B
- IPO Year
- COMP 2021
- ICUI 1992
- Fundamental
- Price
- COMP $7.29
- ICUI $138.67
- Analyst Decision
- COMP Buy
- ICUI Buy
- Analyst Count
- COMP 6
- ICUI 4
- Target Price
- COMP $10.75
- ICUI $199.67
- AVG Volume (30 Days)
- COMP 7.7M
- ICUI 339.0K
- Earning Date
- COMP 05-07-2025
- ICUI 05-06-2025
- Dividend Yield
- COMP N/A
- ICUI N/A
- EPS Growth
- COMP N/A
- ICUI N/A
- EPS
- COMP N/A
- ICUI N/A
- Revenue
- COMP $5,629,100,000.00
- ICUI $2,382,046,000.00
- Revenue This Year
- COMP $28.62
- ICUI $0.84
- Revenue Next Year
- COMP $13.58
- ICUI $2.91
- P/E Ratio
- COMP N/A
- ICUI N/A
- Revenue Growth
- COMP 15.23
- ICUI 5.44
- 52 Week Low
- COMP $3.03
- ICUI $93.36
- 52 Week High
- COMP $10.25
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- COMP 35.57
- ICUI 45.36
- Support Level
- COMP $7.04
- ICUI $136.61
- Resistance Level
- COMP $7.91
- ICUI $145.82
- Average True Range (ATR)
- COMP 0.56
- ICUI 10.06
- MACD
- COMP -0.13
- ICUI 0.10
- Stochastic Oscillator
- COMP 12.47
- ICUI 38.37
About COMP Compass Inc.
Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.